The purpose of the company is to conduct clinical trials on rare diseases and to administer medications and provide services in this field, as well as all related activities. The company may participate in other companies, acquire, manage, and dispose of real estate and intellectual property rights, establish subsidiaries and branches in Switzerland and abroad, and perform all legal acts that may be necessary or useful for the purpose of the company or to promote its development or that of group companies. The company may grant direct or indirect financing to third parties, including companies in which it has a direct or indirect interest, or to its direct or indirect subsidiaries, whether through loans or other financing, including within the framework of cash pooling agreements, and may provide security of any kind for their liabilities, including by way of pledges or fiduciary transfers of the company's assets or by guarantees of any kind, whether against payment or not. The company is part of the Uncommon Cures group and may take into account the interests of the Uncommon Cures group in pursuing its corporate purpose.
Outbound Leads by COHAGA